Molecular Endocrinology, Vol 10, 62-75, Copyright © 1996 by Endocrine Society

ARTICLES

Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP- 1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate

C Widmann, W Dolci and B Thorens
Department of Pharmacology and Toxicology, University of Lausanne, Switzerland.

Glucagon-like peptide-1 (GLP-1) stimulates glucose-induced insulin secretion by binding to a specific G protein-coupled receptor linked to activation of the adenylyl cyclase pathway. Here, using insulinoma cell lines, we studied homologous and heterologous desensitization of GLP-1- induced cAMP production. Preexposure of the cells to GLP-1 induced a decrease in GLP-1-mediated cAMP production, as assessed by a 3- to 5- fold rightward shift of the dose-response curve and an approximately 20 percent decrease in the maximal production of cAMP. Activation of protein kinase C by the phorbol ester phorbol 12-myristate 13-acetate (PMA) also induced desensitization of the GLP-1-mediated response, leading to a 6- to 9-fold shift in the EC50 and a 30% decrease in the maximal production of cAMP. Both forms of desensitization were additive, and the protein kinase C inhibitor RO-318220 inhibited PMA- induced desensitization, but not agonist-induced desensitization. GLP-1- and PMA-dependent desensitization correlated with receptor phosphorylation, and the levels of phosphorylation induced by the two agents were additive. Furthermore, PMA-induced, but not GLP-1-induced, phosphorylation was totally inhibited by RO-318220. Internalization of the GLP-1 receptor did not participate in the desensitization induced by PMA, as a mutant GLP-1 receptor lacking the last 20 amino acids of the cytoplasmic tail was found to be totally resistant to the internalization process, but was still desensitized after PMA preexposure. PMA and GLP-1 were not able to induce the phosphorylation of a receptor deletion mutant lacking the last 33 amino acids of the cytoplasmic tail, indicating that the phosphorylation sites were located within the deleted region. The cAMP production mediated by this deletion mutant was not desensitized by PMA and was only poorly desensitized by GLP-1. Together, our results indicate that the production of cAMP and, hence, the stimulation of insulin secretion induced by GLP-1 can be negatively modulated by homologous and heterologous desensitization, mechanisms that involve receptor phosphorylation.

This article has been cited by other articles:

				W. Kim and J. M. Egan The Role of Incretins in Glucose Homeostasis and Diabetes Treatment Pharmacol. Rev., December 1, 2008; 60(4): 470 - 512. [Abstract] [Full Text] [PDF]

				J. Zhou, M. F. A. Livak, M. Bernier, D. C. Muller, O. D. Carlson, D. Elahi, S. Maudsley, and J. M. Egan Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E538 - E547. [Abstract] [Full Text] [PDF]

				C. A. Syme, L. Zhang, and A. Bisello Caveolin-1 Regulates Cellular Trafficking and Function of the Glucagon-Like Peptide 1 Receptor Mol. Endocrinol., December 1, 2006; 20(12): 3400 - 3411. [Abstract] [Full Text] [PDF]

				P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation J. Endocrinol., July 1, 2005; 186(1): 221 - 231. [Abstract] [Full Text] [PDF]

				P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity J. Endocrinol., April 1, 2005; 185(1): 35 - 44. [Abstract] [Full Text] [PDF]

				R. Jorgensen, L. Martini, T. W. Schwartz, and C. E. Elling Characterization of Glucagon-Like Peptide-1 Receptor {beta}-Arrestin 2 Interaction: A High-Affinity Receptor Phenotype Mol. Endocrinol., March 1, 2005; 19(3): 812 - 823. [Abstract] [Full Text] [PDF]

				L. L. Baggio, J.-G. Kim, and D. J. Drucker Chronic Exposure to GLP-1R Agonists Promotes Homologous GLP-1 Receptor Desensitization In Vitro but Does Not Attenuate GLP-1R-Dependent Glucose Homeostasis In Vivo Diabetes, December 1, 2004; 53(suppl_3): S205 - S214. [Abstract] [Full Text] [PDF]

				S. A. Hinke, K. Hellemans, and F. C. Schuit Plasticity of the {beta} cell insulin secretory competence: preparing the pancreatic {beta} cell for the next meal J. Physiol., July 15, 2004; 558(2): 369 - 380. [Abstract] [Full Text] [PDF]

				N. A. Walsh, B. Yusta, M. P. DaCambra, Y. Anini, D. J. Drucker, and P. L. Brubaker Glucagon-Like Peptide-2 Receptor Activation in the Rat Intestinal Mucosa Endocrinology, October 1, 2003; 144(10): 4385 - 4392. [Abstract] [Full Text] [PDF]

				D. M. Kemp and J. F. Habener Insulinotropic Hormone Glucagon-Like Peptide 1 (GLP-1) Activation of Insulin Gene Promoter Inhibited by p38 Mitogen-Activated Protein Kinase Endocrinology, March 1, 2001; 142(3): 1179 - 1187. [Abstract] [Full Text] [PDF]

				T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]

				A. M. F. Salapatek, P. E. MacDonald, H. Y. Gaisano, and M. B. Wheeler Mutations to the Third Cytoplasmic Domain of the Glucagon-Like Peptide 1 (GLP-1) Receptor Can Functionally Uncouple GLP-1-Stimulated Insulin Secretion in HIT-T15 Cells Mol. Endocrinol., August 1, 1999; 13(8): 1305 - 1317. [Abstract] [Full Text]

				L. B. Lester, L. K. Langeberg, and J. D. Scott Anchoring of protein kinase A facilitates hormone-mediated insulin secretion PNAS, December 23, 1997; 94(26): 14942 - 14947. [Abstract] [Full Text] [PDF]

				C. Montrose-Rafizadeh, H. Yang, B. D. Rodgers, A. Beday, L. A. Pritchette, and J. Eng High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor J. Biol. Chem., August 22, 1997; 272(34): 21201 - 21206. [Abstract] [Full Text] [PDF]

				C. Widmann, W. Dolci, and B. Thorens Internalization and Homologous Desensitization of the GLP-1 Receptor Depend on Phosphorylation of the Receptor Carboxyl Tail at the Same Three Sites Mol. Endocrinol., July 1, 1997; 11(8): 1094 - 1102. [Abstract] [Full Text]

				S. K. Mathi, Y. Chan, X. Li, and M. B. Wheeler Scanning of the Glucagon-Like Peptide-1 Receptor Localizes G Protein-Activating Determinants Primarily to the N Terminus of the Third Intracellular Loop Mol. Endocrinol., April 1, 1997; 11(4): 424 - 432. [Abstract] [Full Text]

				C. Widmann, W. Dolci, and B. Thorens Heterologous Desensitization of the Glucagon-like Peptide-1 Receptor by Phorbol Esters Requires Phosphorylation of the Cytoplasmic Tail at Four Different Sites J. Biol. Chem., August 16, 1996; 271(33): 19957 - 19963. [Abstract] [Full Text] [PDF]

				L. Baggio, F. Adatia, T. Bock, P. L. Brubaker, and D. J. Drucker Sustained Expression of Exendin-4 Does Not Perturb Glucose Homeostasis, beta -Cell Mass, or Food Intake in Metallothionein-Preproexendin Transgenic Mice J. Biol. Chem., October 27, 2000; 275(44): 34471 - 34477. [Abstract] [Full Text] [PDF]